GlassScriptPhysician profile
David Bryant Dorofi
NPI 1548261928
$1,457.98
in general payments reported to CMS, 2019-2025
17 companies · $414 in 2025
The $414 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2020: $37.02 · 2021: $86.02 · 2022: $156 · 2023: $309 · 2024: $280 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $408.61 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $316.70 | 2021-2025 | Nucala |
| Genzyme Corporation | $240.61 | 2021-2025 | |
| Intersect Ent, INC. | $129.98 | 2019 | |
| Stryker Corporation | $115.18 | 2019-2022 | |
| Integra Lifesciences Corporation | $33.11 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Medtronic, INC. | $30.56 | 2022 | |
| Genentech USA, INC. | $28.11 | 2023 | Xolair |
| Ars Pharmaceuticals Operations, INC. | $24.69 | 2025 | Neffy |
| Kaleo, INC. | $22.53 | 2024 | Auvi-Q |
| Hikma Pharmaceuticals USA | $19.80 | 2023 | Ryaltris |
| Cochlear Americas | $17.01 | 2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Optinose US, INC. | $16.83 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.15 | 2025 | |
| Aerin Medical INC. | $13.13 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $13.12 | 2023 | Odactra, Ragwitek, Grastek |
| Conmed Corporation | $12.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dorofi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.